Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3796 AL 3810

Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives

de Castro AA, da Cunha EFF, Pereira AF, Soares FV, Leal DHS, Kuca K, Ramalho TC.

Curr Alzheimer Res. 2018;15(12):1161-1178. doi: 10.2174/1567205015666180813150703.

The effects of physical exercise on executive function in community-dwelling older adults living with Alzheimer's-type dementia: A systematic review

Guitar NA, Connelly DM, Nagamatsu LS, Orange JB, Muir-Hunter SW.

Ageing Res Rev. 2018 Nov;47:159-167. doi: 10.1016/j.arr.2018.07.009. Epub 2018 Aug 10.

Effect and Safety of Huannao Yicong Formula () in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Double-Blinded, Donepezil-Controlled Trial

Yang Y, Liu JP, Fang JY, Wang HC, Wei Y, Cao Y, Liu JG, Liu LT, Li H.

Chin J Integr Med. 2019 Aug;25(8):574-581. doi: 10.1007/s11655-018-3054-7. Epub 2018 Aug 14.

Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer's Disease

Tandon A, Singh SJ, Chaturvedi RK.

Biomed Res Int. 2018 Jul 12;2018:1483791. doi: 10.1155/2018/1483791. eCollection 2018.

Beneficial Effect of Multidomain Cognitive Training on the Neuropsychological Performance of Patients with Early-Stage Alzheimer's Disease

Nousia A, Siokas V, Aretouli E, Messinis L, Aloizou AM, Martzoukou M, Karala M, Koumpoulis C, Nasios G, Dardiotis E.

Neural Plast. 2018 Jul 11;2018:2845176. doi: 10.1155/2018/2845176. eCollection 2018.

Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension Study

Salloway S, Marshall GA, Lu M, Brashear HR.

Curr Alzheimer Res. 2018;15(13):1231-1243. doi: 10.2174/1567205015666180821114813.

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study

Timmers M, Streffer JR, Russu A, Tominaga Y, Shimizu H, Shiraishi A, Tatikola K, Smekens P, Börjesson-Hanson A, Andreasen N, Matias-Guiu J, Baquero M, Boada M, Tesseur I, Tritsmans L, Van Nueten L, Engelborghs S.

Alzheimers Res Ther. 2018 Aug 23;10(1):85. doi: 10.1186/s13195-018-0415-6.

Current understanding of Alzheimer's disease diagnosis and treatment

Weller J, Budson A.

F1000Res. 2018 Jul 31;7:F1000 Faculty Rev-1161. doi: 10.12688/f1000research.14506.1. eCollection 2018.

Effects of Physical Activity in Nursing Home Residents with Dementia: A Randomized Controlled Trial

Henskens M, Nauta IM, van Eekeren MCA, Scherder EJA.

Dement Geriatr Cogn Disord. 2018;46(1-2):60-80. doi: 10.1159/000491818. Epub 2018 Aug 24.

Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis

Liu D, Cao B, Zhao Y, Huang H, McIntyre RS, Rosenblat JD, Zhou H.

Neurosci Lett. 2018 Nov 1;686:10-16. doi: 10.1016/j.neulet.2018.08.038. Epub 2018 Aug 29.

Missing Uniform Costs Classification for Alzheimer's Disease Treatment and Care

Maresova P, Kuca K.

Curr Alzheimer Res. 2018;15(14):1297-1303. doi: 10.2174/1567205015666180831103018.

Resveratrol's Potential in the Adjunctive Management of Cardiovascular Disease, Obesity, Diabetes, Alzheimer Disease, and Cancer

Kulashekar M, Stom SM, Peuler JD.

J Am Osteopath Assoc. 2018 Sep 1;118(9):596-605. doi: 10.7556/jaoa.2018.133.

Transcranial magnetic stimulation intervention in Alzheimer's disease: a research proposal for a randomized controlled trial

Marron EM, Viejo-Sobera R, Quintana M, Redolar-Ripoll D, Rodríguez D, Garolera M.

BMC Res Notes. 2018 Sep 5;11(1):648. doi: 10.1186/s13104-018-3757-z.

Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer's Disease

Wiciński M, Wódkiewicz E, Słupski M, Walczak M, Socha M, Malinowski B, Pawlak-Osińska K.

Biomed Res Int. 2018 Aug 16;2018:6091014. doi: 10.1155/2018/6091014. eCollection 2018.

Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment

Dos Santos Picanco LC, Ozela PF, de Fatima de Brito Brito M, Pinheiro AA, Padilha EC, Braga FS, de Paula da Silva CHT, Dos Santos CBR, Rosa JMC, da Silva Hage-Melim LI.

Curr Med Chem. 2018;25(26):3141-3159. doi: 10.2174/0929867323666161213101126.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias